FDA meeting on September 20-21, 2016

Posted in Latest News on September 23, 2016.

pharmacy-pic2

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.



More Latest News

Gov. DeSantis declares a State of Emergency in FL for Hurricane Dorian
August 29, 2019

Under a State of Emergency, a pharmacist, in his or her professional judgment, may be able to refill prescriptions early. Continue reading


Fourth Quarterly Performance Report Released for the 2018-2019 Fiscal Year
August 23, 2019

The Quarterly Performance Report for the fourth quarter of the 2018-2019 fiscal year is now available online. Continue reading